THEMIS
A multinational, randomised, double-blind, placebo-controlled trial to evaluate the effect of ticagrelor 90mg twice daily on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus
- Stage
- klaar
- Medicine
- ticagrelor
- Population
- Diabetes Mellitus
- Phase
- III
- First Patient In
- 15 November 2015
- Last Patient In
- 10 May 2016
- Last Patient Last Visit
- 31 December 2018
National Lead
prof. dr. J.H. Cornel
Cardioloog
Study Director
